A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer's disease.

Published 10/24/2026

Research record: A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer's disease.

Published in Alzheimers Res Ther; first publication date 2026-10-24. PMID 42958309.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-24

Updated

2026-10-31

Disclaimer

professional use

References

Explore more

A Complementary Role for Immunohistochemistry and Next-Generation Sequencing (NGS) for Detection of Methylthioadenosine Phosphorylase (MTAP) Loss in Patients With Non-Small Cell Lung Cancer (NSCLC).

A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer's disease.

Review and references

Explore more

A Complementary Role for Immunohistochemistry and Next-Generation Sequencing (NGS) for Detection of Methylthioadenosine Phosphorylase (MTAP) Loss in Patients With Non-Small Cell Lung Cancer (NSCLC).

Quality Assessment by Flow Cytometry of Peripheral Blood Mononuclear Cells after Very-Long-Term Cryopreservation.

MXene-Integrated Composites for Next-Generation Photoelectrochemical Molecular Diagnostics.